There was more use of ACE-inhibitors, angiotensin 2 blockers and statins in patients with T2D irrespective of HIV-status, whereas use of beta-blockers was more prevalent in HIV-infected patients with T2D. The gene discussed is ACE; the disease is type 2 diabetes mellitus.